Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma. | PeerJ | 2021 | 33986994 | PubTator, text mining | PubMed |
| Recent Understanding and Future Directions of Recurrent Corticotroph Tumors. | Front Endocrinol (Lausanne) | 2021 | 33986726 | PubTator, text mining | PubMed |
| The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma. | Cancer Cell Int | 2021 | 33980246 | PubTator, text mining | PubMed |
| miRNA dysregulation is an emerging modulator of genomic instability. | Semin Cancer Biol | 2021 | 33979676 | PubTator, text mining | PubMed |
| Ubiquitin ligases in cancer: Functions and clinical potentials. | Cell Chem Biol | 2021 | 33974914 | PubTator, text mining | PubMed |
| The Emerging World of Membrane Vesicles: Functional Relevance, Theranostic Avenues and Tools for Investigating Membrane Function. | Front Mol Biosci | 2021 | 33968983 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma. | Front Mol Biosci | 2021 | 33968978 | PubTator, text mining | PubMed |
| The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. | Front Oncol | 2021 | 33968749 | PubTator, text mining | PubMed |
| SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer. | Front Oncol | 2021 | 33968735 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Permitted and restricted steps of human kinetochore assembly in mitotic cell extracts. | Mol Biol Cell | 2021 | 33956511 | PubTator, text mining | PubMed |
| Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process. | Biomolecules | 2021 | 33922633 | PubTator, text mining | PubMed |
| A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma. | J Pers Med | 2021 | 33922244 | PubTator, text mining | PubMed |
| Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis. | J Pers Med | 2021 | 33921427 | PubTator, text mining | PubMed |
| Not So Dead Genes-Retrocopies as Regulators of Their Disease-Related Progenitors and Hosts. | Cells | 2021 | 33921034 | PubTator, text mining | PubMed |
| Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients. | Cancers (Basel) | 2021 | 33917399 | PubTator, text mining | PubMed |
| Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. | Cancers (Basel) | 2021 | 33916325 | PubTator, text mining | PubMed |
| Identification of a Novel Prognostic Signature for Gastric Cancer Based on Multiple Level Integration and Global Network Optimization. | Front Cell Dev Biol | 2021 | 33912555 | PubTator, text mining | PubMed |
| Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors. | Neuro Oncol | 2021 | 33908609 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy. | Open Biol | 2021 | 33906413 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=45